TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05821413

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Data to care
Description: Participants meet with a case manager who asks about health, basic needs such as housing and finances, and relationships and support systems. A score is assigned that reflects how much support is needed. A care plan is developed to address areas of need. The case manager meets regularly with participants to determine if needs are being met and identify strategies for meeting those needs. Participants with higher scores will receive more intensive contact with case managers, typically every month, until their level of need goes down. All participants will have their level and types of needs reassessed to determine if they need additional support or are moving toward self-management. Participants work with case managers for 6 months.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Participants can use standard case management and other services offered by the clinic.
Study: NCT05127161

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Broad Implementation of Outpatient Stewardship (BIOS) intervention
Description: The BIOS intervention consists of 3 components: (1) online educational modules covering topics related to appropriate antibiotic prescribing for ARTIs, (2) individualized audit and feedback reports displaying clinicians' rates of antibiotic prescription with peer comparison, (3) facilitation provided by the study team and by health system champions to support effective implementation of the intervention and to encourage clinicians to engage meaningfully in the intervention activities.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Broad Implementation of Outpatient Stewardship (BIOS) intervention
Description: The BIOS intervention consists of 3 components: (1) online educational modules covering topics related to appropriate antibiotic prescribing for ARTIs, (2) individualized audit and feedback reports displaying clinicians' rates of antibiotic prescription with peer comparison, (3) facilitation provided by the study team and by health system champions to support effective implementation of the intervention and to encourage clinicians to engage meaningfully in the intervention activities.
Study: NCT05573919

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VivAer Stylus
Description: This device will be used to complete its corresponding procedure, which involves reshaping a patient's nasal sidewall tissue through the delivery of radiofrequency heating.
Study: NCT05375565

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: weight bearing exercises
Description: * Standing knee raise 10 rep x 2sets~* Standing knee bend 10 rep x 2sets~* Standing hip extension 10 rep x 2sets~* Shallow squats 5 rep x 2 sets After 4 week gradually restricting the use of assistive device when patient become able to walk and stand for 10 mins then add stair climbing and descending with a step height not higher than 7 inch.~The session will be around 45 to 60 minutes on each patient with 2 sessions per week on alternate days to observe the long term effects.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: non weight bearing exercises
Description: * Seated knee flexion 10 rep x 2sets~* Seated knee extension 10 rep x2sets~* Use of stationary bicycle 10 mins~* Side lying leg lift 10 rep x2sets~* Straight leg raise 10 rep x 2sets The session will be around 45 to 60 minutes on each patient with 2 sessions per week on alternate days to observe the long term effects.
Study: NCT05603286

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Home-monitoring
Description: Questionnaires for home-monitoring will be send to the participants 11 weeks after the baseline visit via e-mail using Castor EDC and can be completed using a computer, tablet or smartphone. Home-monitoring can be done together with a parent or guardian, if needed.
Study: NCT04714463

Intervention type: PROCEDURE
Intervention: Implant-based breast reconstruction
Description: All types of implant based breast reconstructions
Study: NCT06091566

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: UCon-Bar
Description: The participant self-administer electrical stimulation to the dorsal genital nerve (DGN) for either 4 weeks or 12 weeks using UCon with the Bar electrode
Study: NCT04714463

Intervention type: PROCEDURE
Intervention: Implant-based breast reconstruction
Description: All types of implant based breast reconstructions

Intervention type: PROCEDURE
Intervention: Autologous breast reconstruction
Description: All types of autologous breast reconstructions

Intervention type: PROCEDURE
Intervention: Autologous breast reconstruction
Description: All types of autologous breast reconstructions

Intervention type: PROCEDURE
Intervention: Combined methods
Description: All types of breast reconstructions combining autologous and implant based techniques

Intervention type: PROCEDURE
Intervention: Combined methods
Description: All types of breast reconstructions combining autologous and implant based techniques
Study: NCT05057312

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enhancing Accessibility to Health Care
Description: Receive enhanced access to vaccination

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enhancing Accessibility to Health Care
Description: Receive enhanced access to vaccination

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enhancing Accessibility to Health Care
Description: Receive enhanced access to vaccination

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Informational Intervention
Description: Receive standard CDC information

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Informational Intervention
Description: Receive standard CDC information

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Informational Intervention
Description: Receive video narratives

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Informational Intervention
Description: Receive video narratives

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Informational Intervention
Description: Receive written narratives

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Informational Intervention
Description: Receive written narratives

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Interview
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interview
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interview
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interview
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interview
Description: Ancillary studies
Study: NCT05476211

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BTL-785F
Description: Radiofrequency
Study: NCT05057312

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interview
Description: Ancillary studies

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study: NCT05360615

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 MG
Description: SGLT2 inhibitors

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT06129994

Intervention type: OTHER
Intervention: Observational
Description: Participants will complete an in-person baseline study visit with fasting blood draw, medical and health history, anthropometrics and vital signs, and surveys. If participants are not currently using a CGM, one will be placed. The LifeData study mobile app will be installed on the participant's smartphone. Over the two-week home monitoring period, participants will be asked to wear the CGM and respond to EMA questions three times daily. After the end of the home monitoring period, a remote visit will be performed in which the CGM will be removed by the study participant at home; the study team will obtain all data available from the CGM and insulin pump (if available); and surveys will be collected.
Study: NCT05891743

Intervention type: DIAGNOSTIC_TEST
Intervention: Patch Test
Description: The Patch Test will include the European baseline series, as well as the epoxy and isocyanate series. Additionally, specific products commonly used in the workplace, such as glues, resins, and paints, will be prepared and included in the testing.
Study: NCT05499819

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Canned black beans, drained and rinsed
Description: Canned black beans, drained and rinsed and consumed in a tortilla wrap

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Canned red kidney beans, drained and rinsed
Description: Canned red kidney beans, drained and rinsed, drained and rinsed and consumed in a tortilla wrap

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Extra-lean ground beef
Description: Extra-lean ground beef, pan-fried and consumed in a tortilla wrap
Study: NCT04872608

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole
Description: Letrozole will be given daily on days 1-28.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palbociclib
Description: Palbociclib will be given daily on days 1-21 and held on days 22-28, as per standard FDA-approved dosing guidelines.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Onapristone ER
Description: Onapristone will be given daily on days 1-28.
Study: NCT06038760

Intervention type: PROCEDURE
Intervention: Resection
Description: Patients undergo a resection from a lesion, and give 40mL of blood
Study: NCT06033586

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Open-label rusfertide
Description: subcutaneous rusfertide
Study: NCT04752527

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: venetoclax combined with decitabine
Description: combination of venetoclax plus decitabine, and sorafenib for patients with high FLT3-ITD allelic ratio. (On day 1 of cycle 1, decitabine 20 mg/m2 will be given intravenously, and will continue for 5 days. Simultaneously the patient will start out with Venetoclax 100mg and progress to 400mg until the 28 day cycle is finished. For patients with high FLT3-ITD allelic ratio, sorafenib was administered at a dose of 400mg orally twice daily, on days 3 through 28.
Study: NCT05232773

Intervention type: PROCEDURE
Intervention: Assessment
Description: Evaluation of clinical and kinematic parameters

Intervention type: PROCEDURE
Intervention: Assessment
Description: Evaluation of clinical and kinematic parameters
Study: NCT05847790

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Invu monitoring belt
Description: INVU monitoring belt used for remote NSTs

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: In-clinic NSTs - standard of care
Study: NCT06154200

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Testosterone gel 4.5%
Description: Testosterone gel applied to eyelids twice per day

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle gel
Description: Vehicle gel applied to eyelids twice per day
Study: NCT06561308

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pucotenlimab
Description: Pucotenlimab is administered at 200mg, q3w，intravenous infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: AUC=4-6，q3w，intravenous infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: 175 mg/m2，q3w，intravenous infusion, administered over 30min.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgery
Description: Transabdominal hysterectomy + bilateral adnexectomy + pelvic lymph node dissection + pelvic-abdominal tumor resection +/- para-abdominal aortic lymph node dissection
Study: NCT06249776

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Supernova revascularization device
Description: Mechanical Thrombectomy
Study: NCT06498635

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study: NCT05495230

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Person-centred integrated care intervention
Description: See arm description.
Study: NCT05315791

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: different methods for maxillary sinus floor elevation
Description: a: 0\~3mm+ground into pieces; b: 0\~3mm+replace the bone; c: 0\~3mm+turn inward to hold up the membrane; d: 3\~5mm+ground into pieces; e: 3\~5mm+replace the bone; f: 3\~5mm+turn inward to hold up the membrane

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: different methods for maxillary sinus floor elevation
Description: a: 0\~3mm+ground into pieces; b: 0\~3mm+replace the bone; c: 0\~3mm+turn inward to hold up the membrane; d: 3\~5mm+ground into pieces; e: 3\~5mm+replace the bone; f: 3\~5mm+turn inward to hold up the membrane

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: different methods for maxillary sinus floor elevation
Description: a: 0\~3mm+ground into pieces; b: 0\~3mm+replace the bone; c: 0\~3mm+turn inward to hold up the membrane; d: 3\~5mm+ground into pieces; e: 3\~5mm+replace the bone; f: 3\~5mm+turn inward to hold up the membrane

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: different methods for maxillary sinus floor elevation
Description: a: 0\~3mm+ground into pieces; b: 0\~3mm+replace the bone; c: 0\~3mm+turn inward to hold up the membrane; d: 3\~5mm+ground into pieces; e: 3\~5mm+replace the bone; f: 3\~5mm+turn inward to hold up the membrane

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: different methods for maxillary sinus floor elevation
Description: a: 0\~3mm+ground into pieces; b: 0\~3mm+replace the bone; c: 0\~3mm+turn inward to hold up the membrane; d: 3\~5mm+ground into pieces; e: 3\~5mm+replace the bone; f: 3\~5mm+turn inward to hold up the membrane

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: different methods for maxillary sinus floor elevation
Description: a: 0\~3mm+ground into pieces; b: 0\~3mm+replace the bone; c: 0\~3mm+turn inward to hold up the membrane; d: 3\~5mm+ground into pieces; e: 3\~5mm+replace the bone; f: 3\~5mm+turn inward to hold up the membrane
Study: NCT05750849

Intervention type: PROCEDURE
Intervention: BLOOD COLLECTION FOR P4 DETERMINATION
Description: Serum progesterone levels on the pregnancy test day
Study: NCT05495230

Intervention type: OTHER
Group type: OTHER
Intervention: Usual care
Description: See arm description.
Study: NCT05984992

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SRN-001
Description: siRNA therapeutics, Self Assembled Micelle inhibitory RNA platform utilized

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.9% Sodium Chloride(Normal saline)
Study: NCT06311513

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Concentrated Bone Marrow Aspirate Injection
Description: Intraoperatively, bone marrow will be harvested from the iliac crest with a commercial kit, it will then be prepared via centrifugation and an injection of the resulting concentrated product (cBMA) will be administered in the operative knee. cBMA is an autologous biologic product.

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham Incision
Description: A 2 mm sham incision will be made in the anatomical site where bone marrow would be harvested.
Study: NCT06498635

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Computed Tomography
Description: Undergo CT
Study: NCT06311513

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Revision Anterior Cruciate Ligament Reconstruction
Description: This is the standard-of-care surgical procedure.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Revision Anterior Cruciate Ligament Reconstruction
Description: This is the standard-of-care surgical procedure.
Study: NCT05902858

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional intubation with hyperangulated videolaryngoscope
Description: After the induction of general anesthesia, the patient will undergo conventional intubation with hyperangulated videolaryngoscope

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intubation with ProVu TM video stylet combined with hyperangulated videolaryngoscope
Description: After the induction of general anesthesia, the patient will undergo intubation with ProVu TM video stylet combined with hyperangulated videolaryngoscope

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intubation with ProVu TM video stylet combined with standard Macintosh laryngoscope
Description: After the induction of general anesthesia, the patient will undergo intubation with ProVu TM video stylet combined with standard Macintosh laryngoscope
Study: NCT06305858

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Prosthetic Surgical Procedure
Description: The population consists of 48 patients divided into two groups:~24 patients Group A experimental group: partial denture surgical procedure~24 patients Group B control group: total denture surgical procedure with patellar resurfacing

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Prosthetic Surgical Procedure
Description: The population consists of 48 patients divided into two groups:~24 patients Group A experimental group: partial denture surgical procedure~24 patients Group B control group: total denture surgical procedure with patellar resurfacing
Study: NCT05807750

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Post-discharge income supplement
Description: $300 income supplement

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced care planning
Description: Enhanced care planning provided by a nurse care manager

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enhanced care planning
Description: Enhanced care planning provided by a nurse care manager
Study: NCT05042466

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trauma
Description: 0.15g. thru 0.33g., M/W/F and monthly 1 time a dose of 1g. to 1.5g monthly. 8 week trial.
Study: NCT06498635

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: Given IV
Study: NCT05026658

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Visibly Digital Acuity Product
Description: The order of testing (two VDAP home environments and ETDRS) will be randomly assigned for each subject as one of four sequences:~1. V1, E, V2~2. E, V1, V2~3. V2, E, V1~4. E, V2, V1~Where E denotes the ETDRS assessment, V1 denotes the VDAP assessment in home environment 1, and V2 denotes the VDAP assessment in home environment 2.~The randomization will be blocked in groups of 4 subjects to ensure balance for the VA testing sequences.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Visibly Digital Acuity Product
Description: The order of testing (two VDAP home environments and ETDRS) will be randomly assigned for each subject as one of four sequences:~1. V1, E, V2~2. E, V1, V2~3. V2, E, V1~4. E, V2, V1~Where E denotes the ETDRS assessment, V1 denotes the VDAP assessment in home environment 1, and V2 denotes the VDAP assessment in home environment 2.~The randomization will be blocked in groups of 4 subjects to ensure balance for the VA testing sequences.
Study: NCT06498635

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Patient Observation
Description: Undergo active surveillance

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study: NCT05943756

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Signature Strengths
Description: The treatment group will complete 6 web-based sessions of Signature Strengths(1 sessions per week for 6 weeks), designed to teach lessons focused on the Aware-Explore-Apply interventional framework. Sessions are approximately 60 minutes long.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: TBI Education Course
Description: The control group will complete 6 web-based sessions of a TBI Education Course(1 sessions per week for 6 weeks), designed to teach lessons based on the TBI Model Systems Knowledge Translation Center's fact sheets. Sessions are approximately 60 minutes long.
Study: NCT06286930

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: anodal trans cranial direct current stimulation (tDCS)
Description: 1 20-minute anodal tDCS stimulation

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: anodal trans cranial direct current stimulation (tDCS)
Description: 1 20-minute anodal tDCS stimulation

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: cathodal trans cranial direct current stimulation (tDCS)
Description: 1 20-minute cathodal tDCS stimulation

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: cathodal trans cranial direct current stimulation (tDCS)
Description: 1 20-minute cathodal tDCS stimulation
Study: NCT05275829

Intervention type: OTHER
Intervention: Tele simulation
Description: Interactive tele simulation sessions utilising web-based video-conferencing technology (WebEx platform).
Study: NCT06511505

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TEMPUS AI-enabled ECG-based Screening Tool
Description: The AI-enabled ECG-based screening tool, Tempus Next software, analyzes 12-lead ECG recordings to identify patients at increased risk for undiagnosed cardiovascular diseases, specifically atrial fibrillation (AF) and structural heart disease (SHD). Clinicians in the intervention group will receive a risk assessment for AF and SHD each time they order an ECG for their patients.
Study: NCT05061225

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity counselling
Description: Educational content on several topics regarding physical activity and its implementation in daily living
Study: NCT06312007

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Semi seated position
Description: The patient is positioned 45-90 degrees

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Semi seated position
Description: The patient is positioned 45-90 degrees

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: side lying position
Description: Side lying position

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: side lying position
Description: Side lying position